Lotus Pharmaceutical   Report issue

Contributed to NME For profit Phase 3 Phase 4
Founded: Taipei Taiwan (1966)
Status: Acquired by Alvogen (2014)

Organization Overview

First Clinical Trial
2004
NCT00334178
First Marketed Drug
2010
levetiracetam (keppra)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

LOTUS PHARM CO LTD